• About us
• Contact

Advertisement

Product › Details

NOSO-502 (Nosopharm)

	Next higher product group	antibiotic
	Status	2018-02-12 development pp existent
	Organisation	Nosopharm SAS

Record changed: 2023-07-10

Advertisement

More documents for antibiotic

• [1] Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow....
• [2] Seres Therapeutics, Inc.. (8/6/24). "Press Release: Seres Therapeutics Announces Signing of Vowst Asset Purchase Agreement with Nestlé Health Science". Cambridge, MA....
• [3] Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhei...
• [4] Hikma Pharmaceuticals plc. (6/17/24). "Press Release: Hikma Acquires Xellia’s Differentiated Portfolio and Enhances Injectables Pipeline, Manufacturing Capabilities and R&D". London....
• [5] Seres Therapeutics, Inc.. (6/6/24). "Press Release: Seres Therapeutics Enters into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science". Cambridge, MA....
• [6] BioVersys AG. (5/7/24). "Press Release: BioVersys Announces Expansion of Strategic Collaboration with GSK and Extension of its Series C Round by CHF 12.3 Million". Basel....
• [7] Precisio Biotix Therapeutics, Inc.. (3/1/24). "Press Release: Precisio Biotix Therapeutics Acquires London-headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists". Dover, DE....
• [8] Omnix Medical Ltd.. (2/20/24). "Press Release: Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6". Jerusalem....
• [9] Antabio SAS. (12/12/23). "Press Release: Antabio Raises €25 Million in Series B Financing". Labège....
• [10] Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.